Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Covestro AG is a leading global manufacturer of high-tech polymer materials, specializing in polyurethanes, polycarbonates, and related specialty chemicals. Headquartered in Leverkusen, Germany, the company develops and produces raw materials such as isocyanates, polyols, thermoplastic polyurethanes, and impact-resistant plastics like Makrolon, serving diverse industries including automotive, construction, electrical and electronics, furniture, healthcare, and sports and leisure. Its products enable applications in thermal insulation, coatings, adhesives, electric vehicle batteries, solar panel frames, and consumer goods like footwear and mattresses. Operating through two main segments—Performance Materials and Solutions & Specialties—Covestro emphasizes innovation, sustainability, and circular economy principles, aiming for climate neutrality by 2035 and full circularity with 100% alternative raw materials. With around 17,500 employees and production at 46 sites worldwide, it drives the transformation toward eco-friendly materials, including renewable feedstocks and recycling technologies. Acquired by Abu Dhabi National Oil Company's subsidiary XRG in December 2025, Covestro continues to shape the polymer industry's sustainable future.
€60.50
+€0.20 (+0.33%)
EOD Aug 14, 2026
The business is unprofitable at the operating level (-3.34% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 8.7% YoY. Margins deteriorated 3.5pp alongside, both lines moving the wrong way.
Free cash flow declined 418% versus the prior year, cash generation momentum has weakened. ROIC dropped from 0.22% to -3.43%, capital efficiency is deteriorating.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€12.94B
▼ -8.7% YoY
Net Income (TTM)
-€643M
▼ -136.4% YoY
Op. Margin
-3.34%
▼ -3.5pp YoY
ROIC
-3.43%
▼ -3.6pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-€283M
▼ -418.0% YoY
Op. Cash Flow (TTM)
-€189M
▼ -123.8% YoY
Net Debt
€2.37B
Cash & Equiv.
€767M
3Y CAGR: -10.4%
Continue Research
Covestro (1COV.XFRA)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in .
On quality, Covestro scores 8/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 0.0%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Covestro scores 8 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -3.3% operating margin and a -3.4% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Covestro pays a regular dividend of about €0.01 per share per year (typically in quarterly installments), a yield of roughly 0.0% at the current price. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For 1COV.XFRA's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. you should weigh 1COV.XFRA's valuation and scores 8/100 on quality (lower-quality). It also yields about 0.0%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.